P2-350: prescribing aerobic exercise to older adults with alzheimer's disease

Fang Yu,Ulf Bronas,Daniel Veith
DOI: https://doi.org/10.1016/j.jalz.2014.05.1029
2014-01-01
Alzheimer s & Dementia
Abstract:A large epidemiological literature indicates that physical activity is associated with reduced risk for AD. Many RCTs have found that aerobic exercise improved executive function, memory, and attention in individuals without AD, but others did not. To help interpret these mixed findings, at least 5 meta-analyses have been conducted, demonstrating that aerobic exercise produced mild-to-moderate cognitive gains in in individuals without dementia. Aerobic exercise also improved cognition in persons with mild cognitive impairment (MCI) and dementia. Further, a meta-analysis showed that aerobic exercise significantly improved memory in persons with MCI (Hedge's g=0.237, p=.05) but not in those without MCI (g=0.096, p=.143). Together, these findings argue for the potential therapeutic effect of aerobic exercise on cognition in AD. However, aerobic exercise studies in AD are few and the methods and doses of exercise prescription varies greatly. More importantly, it is often unclear how exercise intensity was prescribed ascertained during delivery. We're conducting a randomized controlled trial (RCT: NIH 1R01AG043392-01A1), to investigate the effects of a novel 6-month, individualized, moderate-intensity cycling intervention on cognition and hippocampal volume in community-dwelling older adults with mild-to-moderate AD. In this study, we have developed a cycle ergometer protocol for prescribing moderate-intensity cycling that is feasible for older adults with AD. Moderate intensity is assessed using a symptom-limited branched cycle-ergometer test with subjects pedaling at a comfortable speed (50-70rpm). The intensity of cycling is increased every 2 minutes by increasing the Watts to achieve an increase in energy expenditure of 1 MET per stage. The intensity is adjusted to allow for a minimum of 4 stages to be achieved during the test while achieving volitional fatigue within 8-12 minutes for assessment of peak oxygen consumption. Heart rate reserve is derived from the test and moderate intensity is prescribed as 65-75% of the heart rate reserve. The cycle-ergometer protocol builds on our preliminary studies and is reliable for ensuring standardized, yet individualized exercise prescriptions to ensure treatment fidelity.
What problem does this paper attempt to address?